Mary McCleary

Senior Manager, QA at Fibrogen Inc

Mary McCleary's Professional Contact Details

Email (Verified)

****@fibrogen.com

Get Email Address

(415) 978-1200

Location

San Francisco, California, US

Company

Fibrogen Inc

Person Seniority

manager

Mary McCleary's Current Company Details

Fibrogen Inc

San Francisco, California, US • 230 Employees

biotechnology

FibroGen, Inc., headquartered in San Francisco, CA with subsidiary offices in Beijing and Shanghai, PRC, is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the company's most advanced product candidate, is an oral small molecule inhibitor of HIF prolyl hydroxylase activity in Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD) and is entering Phase 3 development for anemia in lower risk myelodysplastic syndromes (MDS). Pamrevlumab, a fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer, and Duchenne muscular dystrophy (DMD). FibroGen is also developing a biosynthetic cornea in China. For more information, please visit www.fibrogen.com.

Public Symbol

FGEN

Founded Year

1993

Organization Website

fibrogen.com

Organization Languages

English

Organization Revenue

179600

Current Technologies

at&t dns